TORONTO , Nov. 5, 2025 /CNW/ - argenx SE (EURONEXT: ARGX) (Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Microbot Medical (MBOT – Research Report), Argenx Se (ARGX – Research Report) and AnaptysBio (ANAB –...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update...
In a report released today, Yaron Werber from TD Cowen reiterated a Buy rating on Argenx Se, with a price target of $800.00. The company’s shares closed yesterday at $812.95.Elevate Your Investing Strategy:...
Evercore ISI analyst Gavin Clark-Gartner maintained a Buy rating on Argenx Se yesterday and set a price target of $775.00. The company’s shares closed yesterday at $799.56.Elevate Your Investing Strategy:...
In a report released on October 8, Luca Issi from RBC Capital maintained a Buy rating on Argenx Se. The company’s shares closed yesterday at $804.90.Elevate Your Investing Strategy: Take advantage of...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Argenx Se...
Goldman Sachs analyst maintained a Buy rating on Argenx Se today and set a price target of $916.00. The company’s shares closed yesterday at $767.33.Elevate Your Investing Strategy: Take advantage of...
These three firms in the fast-changing healthcare sector stand out to analysts for their strong product lineups, defensible technology, and notable pipelines.
NEW YORK , Aug. 16, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of argenx SE ("argenx" or the "Company") (NASDAQ: ARGX). Such investors are advised...